<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        3005222102
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2010
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        COMPOUND SODIUM LACTATE INFUSION
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        SODIUM CHLORIDE,POTASSIUM CHLORIDE, CALCIUM CHLORIDE,SODIUM LACTATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        6,0.40,0.27,3.2
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        1000
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bag
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        16.10
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Pharmaceutical Solution Industries (PSI)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Pharmaceutical Solution Industries (PSI)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 444]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Pharmaceutical Solution Industries (PSI)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Pharmaceutical Solution Industries (PSI)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        B05XA31 
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Compound Sodium Lactate Infusion is a solution of the following substances in<br />water: &bull; sodium chloride &bull; potassium chloride &bull; Calcium chloride dihydrate &bull;<br />sodium lactate. Compound Sodium Lactate Infusion is used:<br />&bull; To treat a loss of body water and chemicals (e.g. by heavy sweating, kidney disorders)</p><p>&bull; To treat you, if the volume of blood in your blood vessels is low (hypovolaemia) or if you have low blood pressure (hypotension)</p><p>&bull; in metabolic acidosis (when the blood becomes too acidic).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>You must NOT receive Compound Sodium Lactate Infusion if you are<br />suffering from any of the following conditions</p><p>&bull; If you&rsquo;re a newborn (less than 28 days old) receiving ceftriaxone (an antibiotic)</p><p>&bull; If you&rsquo;re allergic to sodium lactate or any of the other ingredients in Compound Sodium Lactate (listed in section 6)</p><p>&bull; When there is too much fluid in the spaces around the cells of the body (extracellular hyperhydration)</p><p>&bull; When there is a larger volume of blood in the blood vessels than there should be (hypervolaemia)</p><p>&bull; Severe kidney failure (when your kidneys do not work well and you require dialysis)<br />&bull; Uncompensated heart failure. This is heart failure that is not adequately treated and causes symptoms such as: &ndash; shortness of breath &ndash; swelling of the ankles</p><p>&bull; Higher levels of potassium in the blood than normal (hyperkalaemia)</p><p>&bull; Higher levels of calcium in the blood than normal (hypercalcaemia)</p><p>&bull; A disorder in which the blood becomes too alkaline (metabolic alkalosis)</p><p>&bull; Liver disease that causes fluid to build up within the abdomen (ascitic cirrhosis)</p><p>&bull; your blood is too acidic which is life-threatening (severe metabolic acidosis)</p><p>&bull; A particular type of metabolic acidosis (lactic acidosis)</p><p>&bull; Severe liver disease (when the liver does not function properly and requires very intensive treatment)</p><p>&bull; Poor lactate metabolism (this occurs in severe liver disease, as lactate is removed by the liver)</p><p>&bull; If you are taking cardiac glycosides (cardiotonics) used to treat heart failure, such as digitalis or digoxin (see also &ldquo;Taking other medicines&rdquo;)</p><p><strong>Warnings and precautions</strong><br />Talk to your doctor or nurse before receiving Compound Sodium Lactate Infusion if you have or have had any of the following medical conditions:</p><p>&bull; if you&rsquo;re receiving ceftriaxone (an antibiotic) (see also &ldquo;Other medicines and Compound Sodium Lactate Infusion&rdquo;) &bull; Heart failure<br />&bull; Respiratory failure (lung disease) (special monitoring may be required in the above conditions)</p><p>&bull; Poor kidney function</p><p>&bull; Higher levels of chloride in the blood than normal (hyperchloraemia)</p><p>&bull; High blood pressure (hypertension)<br />&bull; Buildup of fluid under the skin, affecting all parts of the body (general oedema)</p><p>&bull; Buildup of fluid under the skin, particularly around the ankles (peripheral oedema)</p><p>&bull; Buildup of fluid in the lungs (pulmonary oedema)</p><p>&bull; High blood pressure during pregnancy (pre-eclampsia)</p><p>&bull; A disease that causes high levels of a hormone called aldosterone (aldosteronism)</p><p>&bull; Higher levels of sodium in the blood than normal (hypernatraemia) or any other condition associated with sodium retention<br />(when the body retains too much sodium), such as treatment with steroids<br />(See also below, &ldquo;Taking other medicines&rdquo;).</p><p>&bull; Heart disease of any type<br />&bull; Any condition that means that you are more likely to have high blood levels of potassium (hyperkalaemia), such as:</p><p>&ndash; Kidney failure<br />&ndash; Adrenocortical insufficiency (this disease of the adrenal gland affects hormones that control the concentration of chemicals in the body)<br />&ndash; Acute dehydration (a loss of water from the body, e.g. due to vomiting or diarrhoea).</p><p>&ndash; Extensive tissue damage (as can occur in severe burns) Close monitoring of your blood potassium levels is required.<br />&bull; Diseases associated with high levels of vitamin D (e.g. sarcoidosis, a disease affecting the skin and internal organs)</p><p>&bull; Kidney stones</p><p>&bull; Poor liver function &bull; Diabetes</p><p>&bull; If you have a condition that could cause high levels of vasopressin, a hormone regulating fluid in your body. You may have too much vasopressin in your body because, for example: - You have had a sudden and serious illness - You are in pain - you have had surgery - You have infections, burns or brain disease - You have diseases linked to your heart, liver, kidneys or central nervous system - Because you are taking certain medicines (see also below other medicines and &lsquo;Compound Sodium Lactate Infusion&rsquo;). This may increase the risk of low levels of sodium in your blood and can lead to headache, nausea, seizures, lethargy, coma, swelling of the brain and death. Brain swelling increases the risk of death and brain damage.&nbsp;People who are at higher risk of brain swelling are: - Children - Women (particularly if you are of a fertile age) - People who have problems with their brain fluid levels, for example, because of meningitis, bleeding in the skull or a brain injury. When you are given this infusion, your doctor will&nbsp; take blood and urine samples to monitor: &bull; The amount of fluid in your body</p><p>&bull; The amount of chemicals such as sodium and potassium in your blood (your plasma electrolytes)</p><p>&bull; The acidity of your blood and urine (your acid-base balance).</p><p>&nbsp;</p><p><strong>Other medicines and Compound Sodium Lactate Infusion</strong><br />Tell your doctor or nurse if you are taking, have recently taken or might take any other medicines. It is particularly important that you inform your doctor if you are taking: &bull; Ceftriaxone (an antibiotic), this should not be given through the same infusion line, unless thoroughly flushed. &bull; cardiac glycosides (cardiotonics) such as digitalis or digoxin used to treat heart failure, must not be used with Compound Sodium Lactate Infusion (see also section &ldquo;You must NOT receive Compound Sodium Lactate Infusion if you are suffering from&hellip;&rdquo;). The effects of these drugs can be increased by calcium. This can lead to life threatening changes to the heart rhythm &bull; Corticosteroids (anti-inflammatory medicines) These medicines can cause the body to accumulate sodium and water, leading to: &bull; Tissue swelling due to fluid collection under the skin (oedema) &bull; High blood pressure (hypertension). The following medicines can increase the concentration of potassium in the blood. This effect can be life-threatening. A rise in the blood potassium levels is more likely to occur if you have kidney disease. &bull; Potassium-sparing diuretics (certain water tablets, e.g. amiloride, spironolactone, triamterene) (Note that these medicines may be included in combination medicinal products) &bull; Angiotensin converting enzyme (ACE) inhibitors (used to treat high blood pressure) &bull; Angiotensin II receptor antagonists (used to treat high blood pressure).&bull; Tacrolimus (used to prevent rejection of a transplant and to treat some skin diseases) &bull; Cyclosporin (used to prevent rejection of a transplant).Some medicines act on the hormone vasopressin. These may include: &bull; Anti-diabetic medication (chlorpropamide) &bull; Cholesterol medicine (clofibrate) &bull; Some cancer drugs (vincristine, ifosfamide, and cyclophosphamide) &bull; Selective serotonin reuptake inhibitors (used to treat depression) &bull; Antipsychotics &bull; Opioids for severe pain relief &bull; Medicines for pain and/or inflammation (also known as NSAIDs) &bull; Medicines that imitate or strengthen the effects of vasopressin such as desmopressin (used to treat increased thirst and urination), terlipressin (used to treat bleeding of the gullet) and oxytocin (used to induce labour) &bull; Anti-epileptic medication (carbamazepine and oxcarbazepine) &bull; Diuretics (water tablets). Other medicines that can affect or be affected by Compound Sodium Lactate Infusion include: &bull; Thiazide diuretics such as hydrochlorothiazide or chlortalidone &bull; Vitamin D &bull; Bisphosphonates (to treat bone diseases such as osteoporosis) &bull; Fluoride (for the teeth and bones) &bull; Fluoroquinolones (a type of antibiotic, including ciprofloxacin, norfloxacin, ofloxacin) &bull; Tetracycline&rsquo;s (a type of antibiotic, including tetracycline) &bull; Acidic medicines, including: &ndash; salicylates used to treat inflammation (aspirin) &ndash; barbiturates (sleeping tablets) &ndash; lithium (used to treat psychiatric illness) &bull; Alkaline (basic) medicines including: &ndash; sympathomimetics (stimulant medicines such as ephedrine and pseudoephedrine, used in cough and cold preparations) &ndash; Other stimulants (e.g. dexamphetamine, phenfluramine). Compound Sodium Lactate Infusion with food and drink You should ask your doctor about what you can eat or drink</p><p><strong>Pregnancy, breast-feeding and fertility</strong><br />If you are pregnant of breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or nurse for advice before taking this medicine. Compound Sodium Lactate Infusion can be used safely during pregnancy or breast-feeding. Your doctor will monitor the levels of chemicals in your blood and the amount of fluid in your body. Calcium can reach your unborn baby through the placenta and, after birth, through the breast milk. However, if another medicine is to be added to your solution for infusion during pregnancy or breast-feeding you should: &bull; consult your doctor<br />&bull; read the Package Leaflet of the medicine that is to be added.</p><p><strong>Driving and using machines </strong></p><p>Ask your doctor or pharmacist for advice before driving or using machines</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>You will be given Compound Sodium Lactate Infusion by a doctor or nurse. Your doctor will decide on how much you need and when it is to be given. This will depend on your age, weight, condition and the reason for treatment. The amount you are given may also be affected by other treatments you are receiving. You should NOT be given Compound Sodium Lactate Infusion if there are particles floating in the solution or if the pack is damaged in any way. Compound Sodium Lactate Infusion will usually be given to you through a plastic tube attached to a needle in a vein. Usually a vein in your arm is used to give you the infusion. However, your doctor may use another method to give you the medicine. Before and during the infusion, your doctor will monitor: &bull; The amount of fluid in your body &bull; The acidity of your blood and urine &bull; The amount of electrolytes in your body (particularly sodium, in patients with high level of the vasopressin, or if you are taking other medicines which increase the effect of vasopressin). Any unused solution should be thrown away. You should NOT be given an infusion of Compound Sodium Lactate Infusion from a bag that has been partly used. If you receive more Compound Sodium Lactate Infusion than you should If you are given too much Compound Sodium Lactate Infusion (over-infusion) or it is given too fast, this may lead to the following symptoms: &bull; Water and/or sodium (salt) overload with build-up of liquid in the tissues (oedema) causing swelling &bull; Hyperkalaemia (higher levels of potassium in the blood than normal) especially in patients with kidney failure, causing symptoms such as: &ndash; Pins and needles in the arms and legs (paraesthesia) &ndash; Muscle weakness &ndash; An inability to move (paralysis) &ndash; An irregular heartbeat (cardiac arrhythmias) &ndash; Heart block (a very slow heartbeat) &ndash; Cardiac arrest (the heart stops beating; a life-threatening situation) &ndash; Confusion &ndash; hypercalcaemia (higher levels of calcium in the blood than normal) causing symptoms such as: - A decreased appetite (anorexia) - Feeling sick (nausea) - Vomiting - Constipation - Abdominal pain - Mental disturbances such as irritability or depression - Drinking lots of water (polydipsia) - producing more urine than normal (polyuria) - Kidney disease due to build-up of calcium in the kidneys (nephrocalcinosis) - Kidney stones - Coma (unconsciousness) - Chalky taste - Redness (hot flushes) - Dilatation of the blood vessels in the skin (peripheral vasodilatation). &bull; Hypokalaemia (lower levels of potassium in the blood than normal) and metabolic alkalosis (when the blood becomes too basic), especially in patients with kidney failure, causing symptoms such as: &ndash; Mood changes &ndash; Tiredness &ndash; Shortness of breath &ndash; Stiffness of the muscles &ndash; Twitching of the muscles &ndash; Contraction of muscles. If you develop any of these symptoms you must inform your doctor immediately. Your infusion will be stopped and you will be given treatment depending on the symptoms. If a medicine has been added to your Compound Sodium Lactate Infusion before over-infusion occurs, that medicine may also cause symptoms. You should read the Package Leaflet of the added medicine for a list of possible symptoms.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. If you have any of the following symptoms you should tell your doctor or nurse immediately. These may be signs of a very severe or even fatal hypersensitivity (allergic) reaction called anaphylactic shock: &bull; Hives (urticaria) which may be localised to a part of the body or widespread &bull; Skin rash &bull; Redness of the skin (erythema) &bull; Itching (pruritus) &bull; Skin swelling (angioedema) &bull; Coughing &bull; Narrowing of the airways causing difficulty breathing (bronchospasm) &bull; A fast heartbeat (tachycardia) &bull; A slow heartbeat (bradycardia) &bull; Decreased blood pressure &bull; Chest discomfort or pain &bull; Anxiety &bull; Tightness of the chest (making it difficult to breathe) &bull; Shortness of breath (dyspnea) &bull; Flushing &bull; Throat irritation &bull; Pins and needles (paraesthesia) &bull; Reduced sense in the mouth (hypoesthesia oral) &bull; Altered taste (dysgeusia) &bull; Fever (pyrexia) &bull; Nausea &bull; Headache - Higher levels of potassium in the blood than normal (hyperkalaemia) Low levels of sodium in the blood that may be acquired during hospitalization (nosocomial hyponatraemia) and related neurological disorder (acute hyponatraemic encephalopathy). Hyponatraemia can lead to irreversible brain injury and death due to cerebral oedema/swelling see also section 2 &ldquo;Warnings and precautions&rdquo;). Reactions due to the administration technique manifested by one or more of the following symptoms: &bull; Local pain or reaction redness or swelling at the site of infusion &bull; Irritation and inflammation of the vein into which the solution is infused (phlebitis). This can cause redness, pain or burning and swelling along the path of the vein into which the solution is infused. &bull; Rash or itching (pruritus) of the infusion site. Other side effects noted with similar products (other sodium-lactate containing solutions) include: &bull; Other manifestations of hypersensitivity/infusion reactions: a blocked nose (nasal congestion), sneezing, swelling in the throat making it difficult to breathe (laryngeal oedema also called Quincke&rsquo;s oedema), skin swelling (angioedema) &bull; Changes in the concentrations of the chemicals in the blood (electrolyte disturbances) &bull; A larger volume of blood in the blood vessels than there should be (hypervolemia) &bull; panic attack</p><p>&bull; Other reactions due to the administration technique: infection at the site of infusion, escape of the infusion solution into the tissues around the vein (extravasation). This can damage the tissues and cause scarring, numbness at the site of infusion.If a medicine has been added to the solution for infusion, the added medicine may also cause side effects. These side effects will depend on the medicine that has been added. You should read the Package Leaflet of the added medicine for a list of possible symptoms.</p><p>Reporting of side effects If you get any side effect, talk to your doctor or nurse. This includes any possible side effect not listed in this leaflet. By reporting side effects, you can help provide more information on the safety of this medicine</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children. 250 ml bags: Store<br />below 30&deg;C. Compound Sodium Lactate Infusion should NOT be given to you<br />after the expiry date which is stated on the bag after EXP: MM/YYYY. The<br />expiry date refers to the last day of that month. You should not be given<br />Compound Sodium Lactate Infusion, if there are particles floating in the<br />solution or if the unit is damaged in any way.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substances are:<br />&bull; Sodium chloride&bull; Potassium chloride &bull; Calcium chloride dihydrate &bull; Sodium<br />lactate. The only other ingredient is water for injections.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Compound Sodium Lactate Infusion is a clear solution, free from visible
particles. It is supplied in plastic bag: 250 ml, 500 ml, 1000 ml, 3000 ml.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Marketing Authorization Holder and Manufacturer<br />Pharmaceutical Solutions Industry Ltd.<br />Industrial Estate, Phase-2,<br />Road No. 208, Str. - 203<br />P O Box 17476<br />Jeddah 21484<br />Western Province<br />Saudi Arabia<br />Phone: +966-12-6361383<br />FAX: +966-12-6379460<br />Website: http://www.psiltd.com<br />This leaflet was revised in May 2021</p><p><br />To report any side effect(s):<br /><br />&bull; Saudi Arabia:<br />The National Pharmacovigilance Centre (NPC):<br />Fax: +966-11-205-7662<br />SFDA Call Center: 19999<br />E-mail: npc.drug@sfda.gov.sa<br />Website: https://ade.sfda.gov.sa</p><p><br />Other GCC States:<br />Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                
03.05.2021
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>مركب لاكتات الصودیوم ھو محلول یتضمن المواد التالیة في الماء:<br />&bull; كلورید الصودیوم &bull; كلورید البوتاسیوم &bull; ثنائي كلورید الكالسیوم<br />&bull; لاكتیت الصودیوم &bull; مركب لاكتات الصودیوم یستخدم لعلاج فقدان میاه الجسم والمواد الكیمیائیة<br />(مثل التعرق الشدید ، واضطرابات الكلى) &bull; لعلاجك إذا كان حجم الدم في الأوعیة الدمویة<br />منخفضًا (نقص حجم الدم) أو إذا كان لدیك انخفاض في ضغط الدم (انخفاض ضغط الدم) &bull;<br />في الحماض الاستقلابي (عندما یصبح الدم حمضیًا جدًا).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>یجب ألا تتلقى مركب لاكتات الصودیوم إذا كنت تعاني من أي من الحالات التالیة:<br />&bull; إذا كنت مولودًا جدیدًا (أقل من ۲۸ یومًا) تتلقى سیفتریاكسون (مضاد حیوي)<br />&bull; إذا كنت تعاني من حساسیة من لاكتات الصودیوم أو أي من المكونات الأخرى في مركب<br />لاكتات الصودیوم (مدرج في القسم ٦) &bull; عندما یكون ھناك الكثیر من السوائل في المساحات<br />المحیطة بخلایا الجسم (فرط الجفاف خارج الخلیة) &bull; عندما یزید حجم الدم في الأوعیة<br />الدمویة اكثر مما یجب &bull; الفشل الكلوي الحاد (عندما لا تعمل كلیتك جیدًا وتحتاج إلى غسیل<br />الكلى) &bull; قصور القلب غیر المكافئ (فشل القلب الذي لا یتم علاجھ بشكل كاف ویسبب أعراضًا مثل: -<br />ضیق التنفس - تورم الكاحلین) &bull; ارتفاع مستویات البوتاسیوم في الدم عن المعدل الطبیعي (فرط<br />بوتاسیوم الدم) &bull; ارتفاع مستویات الكالسیوم في الدم عن المعدل الطبیعي (فرط كالسیوم الدم)<br />&bull; اضطراب یصبح فیھ الدم قلویًا جدًا (قلاء استقلابي) &bull; مرض الكبد الذي یتسبب في تراكم<br />السوائل داخل البطن (تلیف الكبد الحاد). &bull; دمك شدید الحموضة وھو ما یھدد الحیاة (الحماض<br />الأیضي الحاد) &bull; نوع معین من الحماض الایضي (الحماض اللبني) &bull; مرض الكبد الحاد<br />(عندما لا یعمل الكبد بشكل صحیح ویتطلب علاجًا مكثفًا للغایة) &bull; ضعف استقلاب اللاكتات<br />(یحدث ھذا في مرض الكبد الحاد ، حیث تتم إزالة اللاكتات بواسطة الكبد) &bull; إذا كنت تتناول<br />الجلیكوسیدات المستخدمة لعلاج قصور القلب ، مثل الدیجیتال أو الدیجوكسین (انظر أیضًا<br />&quot;تناول أدویة أخرى&quot;).</p><p>المحاذیر والإحتیاطات<br />تحدث إلى طبیبك أو ممرضك قبل تلقي مركب لاكتات الصودیوم إذا كان لدیك أو عانیت من<br />أي من الحالات الطبیة التالیة: &bull; إذا كنت تتلقى عقار السیفتریاكسون (مضاد حیوي).&bull; فشل<br />القلب.&bull; فشل الجھاز التنفسي (أمراض الرئة) (قد یلزم متابعة خاصة في الحالات المذكورة<br />أعلاه).&bull; ضعف وظائف الكلى.&bull; ارتفاع مستویات الكلورید في الدم عن المعدل الطبیعي (فرط<br />كلور الدم).&bull; ارتفاع ضغط الدم (ارتفاع ضغط الدم).&bull; ترسب السوائل تحت الجلد ، مما یؤثر<br />على جمیع أجزاء الجسم (الوذمة).&bull; ترسب السوائل تحت الجلد ، خاصة حول الكاحلین<br />(الوذمة المحیطیة)&bull; ترسب السوائل في الرئتین (الوذمة الرئویة)<br />&bull; ارتفاع ضغط الدم أثناء الحمل (مقدمات الارتعاج)&bull; مرض یسبب مستویات عالیة من<br />ھرمون یسمى الألدوستیرون (الألدوستیرونیة).&bull; ارتفاع مستویات الصودیوم في الدم عن<br />المعدل الطبیعي (فرط صودیوم الدم) أو أي حالة أخرى مرتبطة بالاحتفاظ بالصودیوم (عندما<br />یحتفظ الجسم بالكثیر من الصودیوم) ، مثل العلاج باستخدام المنشطات (انظر أیضًا أدناه ،<br />&quot;تناول أدویة أخرى&quot;).&bull;&bull; أمراض القلب من أي نوع&bull; أي حالة تعني زیادة احتمال ارتفاع<br />مستویات البوتاسیوم في الدم (فرط بوتاسیوم الدم) ، مثل- فشل كلوي- قصور في القشرة الكظریة<br />(یؤثر مرض الغدة الكظریة على الھرمونات التي تتحكم في تركیز المواد الكیمیائیة في الجسم)- الجفاف<br />الحاد (فقدان الماء من الجسم ، على سبیل المثال بسبب القيء أو الإسھال).- تلف الأنسجة واسعة<br />النطاق (كما یمكن أن یحدث في الحروق الشدیدة) مطلوب رصد دقیق لمستویات البوتاسیوم في الدم.&bull;<br />الأمراض المرتبطة بمستویات عالیة من فیتامین (د) مثل الساركوید ، وھو مرض یصیب الجلد<br />والأعضاء الداخلیة &bull; حصى الكلى&bull; ضعف وظائف الكبد&bull; داء السكري&bull; إذا كانت لدیك حالة<br />یمكن أن تسبب مستویات عالیة من فاسوبریسین ، وھو ھرمون ینظم السائل في جسمك. قد<br />یكون لدیك الكثیر من فاسوبریسین في جسمك لأنھ ، على سبیل المثال:- كان لدیك مرض<br />مفاجئ وخطیر- أنت تشعر بالألم - لقد أجریت لك عملیة جراحیة - لدیك التھابات أو حروق</p><p>أو مرض في الدماغ- لدیك أمراض مرتبطة بقلبك أو الكبد أو الكلى أو الجھاز العصبي<br />المركزي- لأنك تتناول بعض الأدویة (انظر أیضًا أدناه الأدویة الأخرى و مركب كلورید<br />الصودیوم لاكتیت) ھذا قد یزید من خطر انخفاض مستویات الصودیوم في دمك ویمكن أن<br />یؤدي إلى صداع ، غثیان ، نوبات ، خمول ، غیبوبة ، تورم في المخ والموت. تورم الدماغ<br />یزید من خطر الموت وتلف الدماغ. الأشخاص الأكثر عرضة لخطر تورم الدماغ ھم:<br />- الأطفال- النساء (خاصة إذا كنت في سن الخصوبة)- الأشخاص الذین یعانون من مشاكل في<br />مستویات السائل في الدماغ ، على سبیل المثال ، بسبب التھاب السحایا ، نزیف في الجمجمة<br />أو إصابة الدماغ. عندما یتم إعطاء ھذا الدواء سیأخذ طبیبك عینات من الدم والبول لمراقبة:<br />- كمیة السائل في جسمك.- كمیة المواد الكیمیائیة مثل الصودیوم والبوتاسیوم في دمك.<br />- حموضة دمك وبولك , على الرغم من أن مركب لاكتات الصودیوم یحتوي على البوتاسیوم<br />، إلا أنھ لا یحتوي على ما یكفي لعلاج مستویات بلازما الدم منخفضة للغایة من البوتاسیوم<br />(نقص البوتاسیوم الحاد).كلورید الكالسیوم یمكن أن یكون ضارا إذا حقن في أنسجة الجسم,<br />لذلك لا یجب إعطاء مركب لاكتات الصودیوم عن طریق حقنھ في العضلات (الحقن<br />العضلي). أیضًا ، سیبذل طبیبك كل جھد ممكن لتجنب ھروب المحلول إلى الأنسجة المحیطة<br />بالورید.لا یجب إعطاء مركب لاكتات الصودیوم من خلال نفس الإبرة التي یتم بھا نقل الدم.<br />نظرًا لأن مركب لاكتات الصودیوم یمكن أن یتلف خلایا الدم الحمراء أو یتسبب في تجمعھا<br />معًا. مركب لاكتات الصودیوم یحتوي على اللاكتات (مادة موجودة في الجسم) ، فإنھ یمكن أن<br />یجعل دمك قلویًا جدًا. یجب إعطاء مركب لاكتات الصودیوم عنایة خاصة للأطفال الذین تقل<br />أعمارھم عن ٦ أشھر سیأخذ طبیبك في الاعتبار إذا كنت تتلقى التغذیة الوریدیة (التغذیة<br />المقدمة عن طریق الحقن في الورید). إذا تم إعطاؤك مركب لاكتات الصودیوم لفترة طویلة ،<br />فسوف تحصل على مصدر إضافي من العناصر الغذائیة</p><p>الأدویة الأخرى وھذا المنتج.<br />أخبر طبیبك أو ممرضك إذا كنت تتناول ، أو قد اتخذت مؤخرا أو قد تأخذ أي أدویة أخرى.<br />من المھم بشكل خاص أن تخبر طبیبك إذا كنت تأخذ: - سیفتریاكسون (مضاد حیوي) ، لا<br />ینبغي أن یعطى من خلال نفس خط التسریب ، ما لم یتم مسحھ جیدًا.<br />- الجلیكوسیدات القلبیة (أمراض القلب) مثل الدیجیتال أو الدیجوكسین المستخدم لعلاج قصور<br />القلب ، یجب ألا تستخدمھ مع مركب الصودیوم. یمكن تزید آثار ھذه الأدویة عن طریق<br />الكالسیوم الذي یمكن أن یؤدي إلى تغییرات تھدد الحیاة على إیقاع القلب.- الستیرویدات<br />(الأدویة المضادة للالتھابات) یمكن أن تسبب ھذه الأدویة في تراكم الجسم للصودیوم والماء ،<br />مما یؤدي إلى:- تورم الأنسجة بسبب تجمع السوائل تحت الجلد (وذمة) - ارتفاع ضغط الدم<br />(ارتفاع ضغط الدم).الأدویة التالیة یمكن أن تزید من تركیز البوتاسیوم في الدم. ھذا التأثیر<br />یمكن أن یھدد الحیاة من المرجح أن یحدث ارتفاع في مستویات البوتاسیوم في الدم إذا كان<br />لدیك مرض في الكلى:- مدرات البول الموفرة للبوتاسیوم على سبیل المثال (الأمیلوراید ،<br />سبیرونولاكتون ، تریامتیرین) (لاحظ أن ھذه الأدویة یمكن ان تستخدم مع ادویة اخرى).<br />- مثبطات الإنزیم المحول للأنجیوتنسین (یستخدم لعلاج ارتفاع ضغط الدم).- مضادات<br />مستقبلات أنجیوتنسین (تستخدم لعلاج ارتفاع ضغط الدم).-تاكرولیمس یستخدم لمنع رفض عملیة<br />زرع ومعالجة بعض الأمراض الجلدیة - السیكلوسبورین (یستخدم لمنع رفض عملیة الزرع) بعض<br />الأدویة تعمل على ھرمون فاسوبریسین. قد تشمل ھذه:- الأدویة المضادة للسكري<br />(الكلوربروبامید)- أدویة الكولیسترول (كلوفیبرات)- بعض الأدویة المستخدمة لعلاج السرطان<br />(فینكریستین ، إیفوسفامید ، وسیكلوفوسفامید)- مثبطات امتصاص السیروتونین الانتقائیة<br />(تستخدم لعلاج الاكتئاب)- مضادات الذھان- المواد الأفیونیة لتخفیف الألم الشدید<br />- أدویة للألم و / أو الالتھاب (المعروف أیضًا باسم مضادات الالتھاب غیر الستیروئیدیة)<br />- الأدویة التي أ تقوي من آثار فاسوبریسین مثل دیزموبریسین (یستخدم لعلاج زیادة العطش<br />والتبول) ، تیرلیبریسین (یستخدم لعلاج نزیف المريء) والأوكسیتوسین (یستخدم للحث على<br />المخاض)- الأدویة المضادة للصرع (كاربامازیبین وأوكسكاربازیبین)- مدرات البول<br />تشمل الأدویة الأخرى التي یمكن أن تؤثر أو تتأثر بمركب كلورید الصودیوم لاكتیت:<br />- مدرات البول الثیازیدیة مثل ھیدروكلوروثیازید أو كلورالیدون- فیتامین د- البایفوسفونیت<br />(لعلاج أمراض العظام مثل ھشاشة العظام)- الفلورید (للأسنان والعظام)- الفلوروكینولونات<br />(نوع من المضادات الحیویة ، بما في ذلك سیبروفلوكساسین ، نورفلوكساسین ، أوفلوكساسین)<br />- التتراسیكلین (نوع من المضادات الحیویة ، بما في ذلك التتراسیكلین)- الأدویة الحمضیة ،<br />بما في ذلك: - السالیسیلات المستخدمة لعلاج الالتھابات (الأسبرین) - الباربیتورات (أقراص<br />النوم) - اللیثیوم (یستخدم لعلاج الأمراض النفسیة)<br />مركب الصودیوم لاكتیت مع الطعام والشراب<br />یجب أن تسأل طبیبك عما یمكنك أن تأكلھ أو تشربھ خلال استخدامك لمحلول مركب لاكتات<br />الصودیوم.</p><p>الحمل والرضاعة الطبیعیة والخصوبة<br />إذا كنت حاملًا ، أو تعتقدي أنكِ قد تكونین حاملًا أو تخططین لإنجاب طفل ، فاطلبي من<br />طبیبك أو ممرضتك الاستشارة قبل تناول ھذا الدواء.یمكن استخدام مركب لاكتات الصودیوم<br />بأمان أثناء الحمل و الرضاعة الطبیعیة.سیقوم طبیبك بمراقبة مستویات المواد الكیمیائیة في<br />دمك وكمیة السائل في جسمك.یمكن أن یصل الكالسیوم إلى طفلك الذي لم یولد بعد من خلال<br />المشیمة ، وبعد الولادة ، من خلال حلیب الثدي. ومع ذلك ، إذا تم إضافة دواء آخر إلى<br />محلول مركب لاكتات الصودیوم أثناء الحمل أو الرضاعة الطبیعیة ، یجب علیك استشارة<br />طبیبك.<br />القیادة واستخدام الآلات<br />اسأل طبیبك أو الصیدلي للحصول على المشورة قبل القیادة أو استخدام الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>سوف یتم إعطاؤك مركب لاكتات الصودیوم من قبل طبیب أو ممرضة. سیقرر طبیبك مقدار</p><p>ما تحتاجھ ومتى یتم إعطاؤه. ھذا یعتمد على عمرك والوزن والحالة وسبب العلاج. قد تتأثر<br />الكمیة الذي قدمت لك من مركب لاكتات الصودیوم أیضًا بالعلاجات الأخرى التي تتلقاھا.<br />یجب عدم إعطاؤك مركب الصودیوم لاكتیت اذا كان ھناك جسیمات تطفو بالمحلول او اذا<br />كانت العبوة تالفة. عادةً ما یتم إعطاؤك مركب لاكتات الصودیوم من خلال أنبوب بلاستیكي<br />متصل بأبرة في الورید.عادة ما یتم استخدام الورید في ذراعك لإعطائك الحقن في الورید.<br />ومع ذلك ، قد یستخدم الطبیب طریقة أخرى لإعطائك الدواء. قبل وأثناء اعطاء المحلول ،<br />سیقوم طبیبك بمراقبة:- كمیة السائل في جسمك- حموضة دمك والبول- كمیة الإلكترولیت في<br />جسمك (خاصة الصودیوم ، في المرضى الذین یعانون من ارتفاع مستوى فاسوبریسین ، أو إذا<br />كنت تتناول أدویة أخرى تزید من تأثیر فاسوبریسین). یجب التخلص من أي محلول غیر<br />مستخدم. یجب عدم إعطاؤك مركب لاكتات الصودیوم&quot; من عبوة تم استخدامھا جزئیًا.<br />إذا تلقیت كمیة أكبر من ھذا الدواء أكثر مما ینبغي:<br />إذا تم إعطاؤك الكثیر من مركب لاكتات الصودیوم (الإفراط في التسریب) أو تم إعطاؤھا<br />بسرعة كبیرة ، فقد یؤدي ذلك إلى الأعراض التالیة:<br />- الماء و / أو الصودیوم (الملح) الزائد مع تراكم السائل في الأنسجة (وذمة) مما تسبب تورم<br />- فرط بوتاسیوم الدم (مستویات البوتاسیوم في الدم أعلى من المعتاد) وخاصة في المرضى<br />الذین یعانون من الفشل الكلوي ، مسببة أعراض مثل:<br />- دبابیس وإبر في الذراعین والساقین - ضعف العضلات - عدم القدرة على الحركة (الشلل)<br />- عدم انتظام ضربات القلب (عدم انتظام ضربات القلب)<br />- كتلة القلب (نبضات بطیئة جدا) - السكتة القلبیة (توقف القلب عن الخفقان ؛ وضع یھدد<br />الحیاة)- الارتباك - فرط كالسیوم الدم (مستویات الكالسیوم في الدم أعلى من المعتاد) مسببة<br />أعراض مثل - انخفاض الشھیة (فقدان الشھیة) - الشعور بالمرض (غثیان) - القيء<br />- الإمساك - وجع بطن - الاضطرابات العقلیة مثل التھیج أو الاكتئاب - شرب الكثیر من الماء<br />- إنتاج كمیة أكبر من البول عن المعتاد - أمراض الكلى بسبب تراكم الكالسیوم في الكلى<br />- حصى الكلى - غیبوبة (فاقد الوعي) - طعم طباشیري - احمرار (الھبات الساخنة)<br />- توسع الأوعیة الدمویة في الجلد (توسع الأوعیة المحیطیة). - نقص بوتاسیوم الدم (انخفاض<br />مستویات البوتاسیوم في الدم عن المعدل الطبیعي) والقلویات الأیضیة (عندما یصبح الدم<br />قاعدیاً جدًا) ، خاصة في المرضى الذین یعانون من قصور كلوي ، مما یسبب أعراضًا مثل:<br />- تغیرات في المزاج - التعب - ضیق في التنفس - تصلب العضلات - الوخز في العضلات<br />- تقلص العضلات. إذا ظھرت علیك أي من ھذه الأعراض ، فعلیك إبلاغ طبیبك على الفور.<br />سیتم إیقاف الدواء وسیتم إعطاؤك العلاج وفقًا للأعراض. إذا تم إضافة دواء إلى مركب<br />لاكتات الصودیوم الخاص بك قبل حدوث الإفراط في التسریب ، فقد یؤدي ھذا الدواء أیضًا<br />إلى ظھور أعراض أخرى. یجب علیك قراءة قسم الأعراض المحتملة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جمیع الأدویة ، یمكن أن یسبب ھذا المنتج آثارًا جانبیة ، على الرغم من عدم حصول<br />الجمیع علیھا. إذا كان لدیك أي من الأعراض التالیة ، یجب علیك إخبار طبیبك أو ممرضتك<br />على الفور: قد تكون ھذه علامات على تفاعل شدید الحساسیة أو قاتل جدًا (حساسیة) یسمى<br />صدمة الحساسیة - الشرى التي یمكن أن تتحول إلى جزء من الجسم أو على نطاق واسع<br />- الطفح الجلدي - احمرار الجلد - الحكة - تورم الجلد (وذمة وعائیة) - السعال - ضیق<br />بالشعب الھوائیة یسبب صعوبة في التنفس (تشنج قصبي) - نبضات سریعة (عدم انتظام دقات<br />القلب) - نبضات بطیئة (بطء القلب) - انخفاض ضغط الدم - ألم في الصدر أو ألم<br />- القلق - ضیق في الصدر (مما یجعل التنفس صعبًا) - ضیق التنفس (ضیق التنفس)<br />- أحمرار بالوجھ - تھیج الحلق - وخز - انخفاض الشعور في الفم (نقص إفرازات الفم)<br />- تغییر الذوق - الحمى - غثیان - صداع الراس - ارتفاع مستویات البوتاسیوم في الدم عن<br />المعدل الطبیعي (فرط بوتاسیوم الدم) - انخفاض مستویات الصودیوم في الدم التي یمكن<br />الحصول علیھا أثناء العلاج في المستشفى (نقص صودیوم الدم في المستشفیات)<br />والاضطرابات العصبیة ذات الصلة (اعتلال الدماغ الحاد بالمرض). - نقص صودیوم الدم<br />یمكن أن یؤدي إلى إصابات دماغیة لا رجعة فیھا والموت بسبب الوذمة الدماغیة / تورم انظر<br />أیضا القسم ۲ &quot;التحذیرات والاحتیاطات&quot;<br />- ردود الفعل الناجمة عن أسلوب اعطاء الدواء التي ممكن ان یظھر فیھا واحد أو أكثر من<br />الأعراض التالیة: - ألم موضعي أو رد فعل احمرار أو تورم في موقع التسریب<br />- تھیج والتھاب الورید الذي یتم فیھ غرس المحلول (التھاب الورید). ھذا یمكن أن یسبب<br />احمرار أو ألم أو حرق وتورم على طول الورید الذي یتم فیھ غرس المحلول.<br />- طفح أو حكة من موقع التسریب.<br />الآثار الجانبیة الأخرى التي لوحظت مع المنتجات المماثلة (المحالیل الأخرى التي تحتوي على لاكتات<br />الصودیوم) تشمل:<br />- المظاھر الأخرى لفرط الحساسیة / تفاعلات التسریب: الأنف المسدودة (احتقان الأنف) ،<br />والعطس ، والتورم في الحلق ، مما یجعل التنفس صعبًا (الوذمة الحنجریة تسمى أیضًا وذمة<br />كوینك) ، تورم الجلد (وذمة وعائیة)<br />- التغیرات في تركیزات المواد الكیمیائیة في الدم (اضطرابات المنحل بالكھرباء)<br />- حجم الدم أكبر في الأوعیة الدمویة مما ینبغي أن یكون (فرط حجم الدم)<br />- نوبة فزع - ردود الفعل الأخرى بسبب أسلوب الاعطاء: العدوى في موقع الحقن ، تسریب<br />المحلول في الأنسجة التي حول الورید .ھذا یمكن أن یتلف الأنسجة ویسبب تندب في موقع<br />التسریب. - إذا تمت إضافة دواء إلى محلول التسریب ، فقد یتسبب الدواء المضاف أیضًا في<br />حدوث آثار جانبیة. تعتمد ھذه الآثار الجانبیة على الدواء الذي تمت إضافتھ.</p><p>الإبلاغ عن الآثار الجانبیة<br />إذا كنت تعاني من أي آثار جانبیة ، فتحدث إلى طبیبك أو ممرضتك. یتضمن ھذا أي أثر جانبي محتمل<br />غیر مدرج في ھذه النشرة. عن طریق الإبلاغ عن الآثار الجانبیة ، یمكنك المساعدة في توفیر المزید<br />من المعلومات حول سلامة ھذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>الحفاظ على ھذا الدواء بعیدا عن مرأى ومدى وصول الأطفال.<br />یخزن عند درجة حرارة لا تتعدى ۳۰ درجة مئویة.<br />لا یجب إعطاء مركب لاكتات الصودیوم لك بعد تاریخ انتھاء الصلاحیة المذكور في الكیس بعد<br />یشیر تاریخ انتھاء الصلاحیة إلى الیوم الأخیر من ذلك الشھر. یجب .EXP: MM / YYYY<br />عدم إعطاؤك مركب لاكتات الصودیوم إذا كانت ھناك جسیمات تطفو في المحلول أو إذا<br />تعرضت العبوة للتلف بأي طریقة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>ما یحتوي على مركب لاكتات الصودیوم للتسریب یحتوي على:<br />المواد الفعالة ھي:<br />&bull; كلورید الصودیوم<br />&bull; كلورید البوتاسیوم<br />&bull; ثنائي كلورید الكالسیوم<br />&bull; اكتات الصودیوم<br />العنصر الآخر ھو الماء للحقن.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>ھو محلول نقي وخالي من الشوائب.<br />یتم توفیره في أكیاس بلاستیكیة: ۲٥۰ مل ، ٥۰۰ مل , ۱۰۰۰ مل, ۳۰۰۰ مل.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>مصنع المحالیل الطبیة.<br />العنوان:المنطقة الصناعیة، المرحلة الثانیة.<br />طریق رقم ۲۰۸ ، شارع ۲۰۳<br />. صندوق برید ۱۷٤۷٦ جدة ۲۱٤۸٤<br />المنطقة الغربیة<br />المملكة العربیة السعودیة<br />+۹٦٦-۱۲- الھاتف: ٦۳٦۱۳۸۳<br />+۹٦٦-۱۲- الفاكس: ٦۳۷۹٤٦۰<br />http://www.psiltd.com: الموقع الالكتروني<br />للإبلاغ عن أي أعراض جانبیة:<br />مركب لاكتات الصودیوم<br />محلول للحقن بالتسریب الوریدى ف.ب<br />رینجر لاكتات<br /> <br />المملكة العربیة السعودیة<br />المركز الوطني للتیقظ الدوائي:<br />+ فاكس: ۹٦٦۱۱۲۰٥۷٦٦۲<br />مركز الإتصال الموحد لھیئة الغذاء والدواء -السعودیة : ۱۹۹۹۹<br />npc.drug@sfda.gov.sa البرید الإلكتروني<br />https://ade.sfda.gov.sa: الموقع الإلكتروني<br />دول الخلیج الأخرى:<br />الرجاء الاتصال بالمؤسسات والھیئات الوطنیة في كل دولة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            03.05.2021
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Compound Sodium Lactate Solution for Infusion BP
(Synonyms: - Ringer Lactate Solution for Infusion)
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                One liter contains:
Sodium Lactate………………………….3.20 g
Sodium Chloride………………………..6.00 g
Potassium Chloride……………………0.40 g
Calcium Chloride 2H2O……………… 0.27 g
Water for injections……………… 1000 ml
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for infusion.
Clear solution, free from visible particles.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Compound Sodium Lactate solution is used in the following indications:<br />- Restoration of extracellular fluid and electrolytes balances or replacement of<br />extracellular fluid loss where isotonic concentrations of electrolytes are sufficient<br />- Short term volume replacement (alone or in association with colloid) in case of<br />hypovolaemia or hypotension.<br />- Regulation or maintenance of metabolic acidosis balance and/or treatment of mild<br />to moderate metabolic acidosis (except lactic acidosis)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Posology</strong><br />Adults, the Elderly and Children:<br />Fluid balance, serum electrolytes and acid-base balance should be monitored<br />before and during administration, with particular attention to serum sodium in<br />patients with increased non-osmotic vasopressin release (syndrome of<br />inappropriate antidiuretic hormone secretion, SIADH) and in patients co-medicated<br />with vasopressin agonist drugs, due to the risk of hospital acquired hyponatraemia<br />(see sections 4.4, 4.5 and 4.8). Monitoring of serum sodium is particularly<br />important for hypotonic fluids.</p><p>Compound Sodium Lactate solution has a tonicity of 278 mOsm/l (approx.)<br />The infusion rate and volume depend on the age, weight, clinical condition (e.g.<br />burns, surgery, head-injury, infections), and concomitant therapy should be<br />determined by the consulting physician experienced in intravenous fluid therapy<br />(see sections 4.4. and 4.8).<br /><u><strong>Recommended dosage:</strong></u><br />The amount of Compound Sodium Lactate solution needed to restore normal blood<br />volume is 3 to 5 times the volume of lost blood.<br />Dosage<br />The recommended flow rate 2.5 ml/kg BW/h.i.e<br />60 Drops/minute or 180 ml/h /70kg BW<br /><u><strong>Use in paediatric patients</strong></u><br />The safety and efficacy of Compound Sodium Lactate solution in children has not<br />been established by adequate and well-controlled trials; however, the use of<br />electrolyte solutions in the paediatric population is referenced in the medical<br />literature. Lactate-containing solutions should be administered with particular<br />caution to neonates and infants less than 6 months of age.<br /><u><strong>Use in geriatric patients</strong></u><br />When selecting the type of infusion solution and the volume/rate of infusion for a<br />geriatric patient, consider that geriatric patients are generally more likely to have<br />cardiac, renal, hepatic, and other diseases or concomitant drug therapy.<br /><u><strong>Method of administration:</strong></u><br />The solution is for intravenous administration through a sterile and non-pyrogenic<br />administration set using aseptic technique. The equipment should be primed with<br />the solution in order to prevent air entering the system.<br />The solution should be inspected visually for particulate matter and discoloration<br />prior to administration. Do not administer unless the solution is clear, free from<br />visible particles and the seal is intact. Do not remove unit from overwrap until<br />ready for use. The inner bag maintains the sterility of the solution. Administer<br />immediately following the insertion of infusion set.<br />Do not connect flexible plastic containers in series in order to avoid air embolism<br />due to possible residual air contained in the primary container. Pressurizing<br />intravenous solutions contained in flexible plastic containers to increase flow rates<br />can result in air embolism if the residual air in the container is<br />not fully evacuated prior to administration. Use of a vented intravenous<br />administration set with the vent in the open position could result in air embolism</p><p>Vented intravenous administration sets with the vent in the open position should<br />not be used with flexible plastic containers.<br />Additives may be introduced before infusion or during infusion through the<br />injection site. When making additions to Compound Sodium Lactate solution,<br />aseptic technique must be used. Mix the solution thoroughly when additives have<br />been introduced. Do not store solutions containing additives.<br />For information on incompatibilities and preparation of the product with additives,<br />please see sections 6.2 and 6.6.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                As for other calcium-containing infusion solutions, concomitant administration of
ceftriaxone and Compound Sodium Lactate solution is contraindicated in newborns
(≤28 days of age), even if separate infusion lines are used (risk of fatal ceftriaxonecalcium
salt precipitation in the neonate's bloodstream). For patients over 28 days
of age please see section 4.4.
Compound Sodium Lactate solution is also contraindicated in patients with
• A known hypersensitivity to sodium lactate.
• Extracellular hyperhydration or hypervolaemia
• Severe renal insufficiency (with oliguria/anuria)
• Uncompensated cardiac failure
• Hyperkalaemia
• Hypercalcaemia
• Metabolic alkalosis
• Ascitic cirrhosis
• Severe metabolic acidosis
• Conditions associated with increased lactate levels (hyperlactataemia) including
lactic acidosis, or impaired lactate utilization, such as severe hepatic insufficiency.
• Concomitant digitalis therapy (see section 4.5 Interactions with other medicinal
products and other forms of interaction)
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Hypersensitivity reactions</strong><br />The infusion must be stopped immediately if any signs or symptoms of a suspected<br />hypersensitivity reaction develop. Appropriate therapeutic countermeasures must<br />be instituted as clinically indicated.<br />Incompatibilities<br />Ceftriaxone<br />In patients older than 28 days (including adults), ceftriaxone must not be<br />administered simultaneously with intravenous calcium-containing solutions,<br />including Compound Sodium Lactate solution, through the same infusion line. If<br />the same infusion line is used for sequential administration, the line must be<br />thoroughly flushed between infusions with a compatible fluid. For patients under<br />28 days please see section 4.3.<br /><strong>Electrolyte balance</strong><br />Hypernatraemia<br />Compound Sodium Lactate solution should only be administered to patients with<br />hypernatraemia after careful consideration of the underlying cause and alternative<br />intravenous fluids. Monitoring of plasma sodium and volume status during<br />treatment is recommended.<br />Compound Sodium Lactate solution should be administered with particular caution<br />in patients with conditions predisposing to hypernatraemia (such as adrenocortical<br />insufficiency, diabetes insipidus or extensive tissue injury) and in patients with<br />cardiac disease.<br />Hyperchloraemia<br />Compound Sodium Lactate solution should only be administered to patients with<br />hyperchloraemia after careful consideration of the underlying cause and alternative<br />intravenous fluids. Monitoring of plasma chloride and acid-base balance during<br />treatment is recommended.<br />Compound Sodium Lactate solution should be administered with particular caution<br />to patients with conditions predisposing to hyperchloraemia (such as renal failure<br />and renal tubular acidosis, diabetes insipidus), and patients with urinary diversion<br />or patients taking certain diuretics (carbonic anhydrase inhibitors eg<br />acetazolamide) or steroids (androgens, estrogens corticosteroids) and in patients<br />with severe dehydration.</p><p>Use in patients with potassium deficiency<br />Although Compound Sodium Lactate solution has a potassium concentration<br />similar to the concentration in plasma, it is insufficient to produce a useful effect in<br />case of severe potassium insufficiency and therefore it should not be used for this<br />purpose.<br />Use in patients at risk for hyperkalaemia<br />Compound Sodium Lactate solution should be administered with particular caution<br />to patients with conditions predisposing to hyperkalaemia (such as severe renal<br />impairment or adrenocortical insufficiency, acute dehydration, or extensive tissue<br />injury or burns) and in patients with cardiac disease. The plasma potassium level of<br />the patient must be particularly closely monitored in patients at risk of<br />hyperkalaemia.<br />Use in patients at risk for hypercalcaemia<br />Calcium chloride is irritant, therefore care should be taken to prevent extravasation<br />during intravenous injection and intramuscular injection must be avoided.<br />Solutions containing calcium salts should be used with caution in patients with<br />conditions predisposing to hypercalcaemia, such as patients with renal impairment<br />and granulomatous diseases associated with increased calcitriol synthesis such as<br />sarcoidosis, calcium renal calculi or a history of such calculi.<br />Fluid balance/renal function<br />Use in patients with renal impairment<br />Compound Sodium Lactate solution should be administered with particular caution<br />to patients with renal impairment. In such patients administration of Compound<br />Sodium Lactate solution may result in sodium and/or potassium retention.<br />Risk of Fluid and/or Solute Overload and Electrolyte Disturbances<br />Depending on the volume and rate of infusion, intravenous administration of<br />Compound Sodium Lactate solution can cause<br />&bull; fluid and/or solute overload resulting in overhydration and, for example,<br />congested states, including pulmonary congestion and oedema.<br />&bull; clinically relevant electrolyte disturbances and acid-base imbalance.<br />Clinical evaluation and periodic laboratory determinations may be necessary to<br />monitor changes in fluid balance, electrolyte concentrations and acid-base balance<br />during prolonged parenteral therapy or whenever the condition of the patient or the<br />rate of administration warrants such evaluation.</p><p>High volume infusion must be used under specific monitoring in patients with<br />cardiac or pulmonary failure and in patients with non-osmotic vasopressin release<br />(including SIADH), due to the risk of hospital-acquired hyponatraemia (see<br />below).<br />Hyponatraemia<br />Patients with non-osmotic vasopressin release (e.g. in acute illness, pain, postoperative<br />stress, infections, burns, and CNS diseases), patients with heart-, liverand<br />kidney diseases and patients exposed to vasopressin agonists (see section 4.5)<br />are at particular risk of acute hyponatraemia upon infusion of hypotonic fluids.<br />Acute hyponatraemia can lead to acute hyponatraemic encephalopathy (cerebral<br />oedema) characterized by headache, nausea, seizures, lethargy and vomiting.<br />Patients with cerebral oedema are at particular risk of severe, irreversible and lifethreatening<br />brain injury.<br />Children, women in the fertile age and patients with reduced cerebral compliance<br />(e.g. meningitis, intracranial bleeding, cerebral contusion and brain oedema) are at<br />particular risk of the severe and life-threatening brain swelling caused by acute<br />hyponatraemia.<br />Use in patients with hypervolaemia, overhydration or conditions causing sodium<br />retention and oedema<br />Compound Sodium Lactate solution should be administered with particular caution<br />to hypervolaemic or overhydrated patients.<br />Due to the sodium chloride content Compound Sodium Lactate solution should be<br />administered with particular caution to patients with conditions that may cause<br />sodium retention, fluid overload and oedema, such as patients with primary<br />hyperaldosteronism, secondary hyperaldosteronism (associated with, e.g.,<br />hypertension, congestive heart failure, renal artery stenosis, or nephrosclerosis), or<br />preeclampsia. (see also Section 4.5)<br />Acid-base balance<br />Use in patients at risk for alkalosis<br />Compound Sodium Lactate solution should be administered with particular caution<br />to patients at risk for alkalosis. Because lactate is metabolized to bicarbonate,<br />administration may result in, or worsen, metabolic alkalosis. Seizure may be<br />precipitated by the alkalosis induced by lactate but this is uncommon</p><p>Other warnings<br />Administration of citrate anticoagulated/preserved blood<br />Due to the risk of coagulation precipitated by its calcium content, Compound<br />Sodium Lactate solution must not be added to or administered simultaneously<br />through the same tubing with citrate anticoagulated/preserved blood.<br />Use in patients with type 2 diabetes<br />Lactate is a substrate for gluconeogenesis. Therefore, glucose levels should be<br />carefully monitored in patients receiving Compound Sodium Lactate.<br />Administration<br />Adding other medication or using an incorrect administration technique might<br />cause the appearance of fever reactions due to the possible introduction of<br />pyrogens. In such case the infusion must be stopped immediately.<br />For information on incompatibilities and preparation of the product with additives,<br />please see sections 6.2 and 6.6.<br />During long term parenteral treatment, a convenient nutritive supply must be given<br />to the patient</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ceftriaxone: See sections 4.3 and 4.4 for more information<br />Drugs leading to an increased vasopressin effect<br />The below listed drugs increase the vasopressin effect, leading to reduced renal<br />electrolyte free water excretion and may increase the risk of hospital acquired<br />hyponatraemia following inappropriately balanced treatment with i.v. fluids (see<br />sections 4.2, 4.4 and 4.8).<br />&bull; Drugs stimulating vasopressin release include: Chlorpropamide, clofibrate,<br />carbamazepine, vincristine, selective serotonin reuptake inhibitors, 3.4-<br />methylenedioxy-N-methamphetamine, ifosfamide, antipsychotics, and narcotics.<br />&bull; Drugs potentiating vasopressin action include: Chlorpropamide, NSAIDs, and<br />cyclophosphamide<br />&bull; Vasopressin analogues include: Desmopressin, oxytocin, terlipressin<br />Other medicinal products increasing the risk of hyponatraemia also include<br />diuretics in general and antiepileptics such as oxcarbazepine.<br />Interaction related to the presence of sodium:<br />Caution is advised when administering Compound Sodium Lactate solution to<br />patients treated with drugs that may increase the risk of sodium and fluid retention<br />(with oedema and hypertension), such as corticosteroids.<br />Interaction related to the presence of potassium:<br />Because of its potassium content, Compound Sodium Lactate solution should be<br />administered with caution in patients treated with agents or products that can cause<br />hyperkalaemia or increase the risk of hyperkalaemia, such as<br />- Potassium-sparing diuretics (amiloride, spironolactone, triamterene, alone or in<br />association).<br />- Angiotensin converting enzyme inhibitors (ACEi) and angiotensin II receptor<br />antagonists<br />- Tacrolimus, cyclosporine<br />Administration of potassium in patients treated with such medications can produce<br />severe and potentially fatal hyperkalaemia, particularly in patients with severe<br />renal insufficiency.<br />Interaction related to the presence of calcium:<br />Administration of calcium may increase the effects of digitalis and lead to serious<br />or fatal cardiac arrhythmia. Therefore, larger volumes or a faster infusion rates<br />should be used with caution in patients treated with digitalis glycosides.</p><p>- Caution is advised when administering Compound Sodium Lactate solution to<br />patients treated with thiazide diuretics or vitamin D, as these can increase the risk<br />of hypercalcaemia.<br />- Bisphosphonates, fluoride, some fluoroquinolones and tetracyclines which are<br />less absorbed (lower availability) when administered with calcium.<br />Interaction related to the presence of lactate (which is metabolized into<br />bicarbonate):<br />Caution is advised when administering Compound Sodium Lactate solution to<br />patients treated with drugs for which renal elimination is pH dependent. Due to the<br />alkalinizing action of lactate (formation of bicarbonate), Compound Sodium<br />Lactate solution may interfere with the elimination of such drugs.<br />- Renal clearance of acidic drugs such as salicylates, barbiturates, and lithium may<br />be increased because of the alkalinisation of urine by the bicarbonate resulting<br />from lactate metabolism.<br />- Renal clearance of alkaline drugs, such as sympathomimetics (e.g. ephedrine,<br />pseudoephedrine) and stimulants (e.g. dexamphetamine sulfate, phenfluramine<br />hydrochloride) may be decreased</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Compound Sodium Lactate solution can be used safely during pregnancy and<br />lactation as long as the electrolyte- and fluid balance is controlled.<br />It is reminded that calcium crosses the placenta and is distributed into breast milk.<br />Compound Sodium Lactate solution should be administrated with special caution<br />for pregnant women during labour particularly as to serum-sodium if administered<br />in combination with oxytocin (see section 4.4, 4.5 and 4.8).<br />When a medication is added, the nature of the drug and its use during pregnancy<br />and lactation have to be considered separately</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There is no information of the effects of Compound Sodium Lactate solution on<br />the ability to operate an automobile or other heavy machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following adverse reactions (listed by MedDRA System Organ Class) have<br />been reported spontaneously during the post-market experience.</p><table border="1" cellspacing="1" cellpadding="1" style="width:100%"><tbody><tr><td style="width:172px">Immune System Disorders</td><td style="width:237px">Hypersensitivity/Infusion reactions including<br />Anaphylactic/Anaphylactoid reaction, possibly<br />manifested by one or more of the following</td></tr><tr><td style="width:172px">&nbsp;</td><td style="width:237px">symptoms: Angioedema, Chest pain, Chest<br />discomfort, Decreased heart rate, Tachycardia,<br />Blood pressure decreased, Respiratory distress,<br />Bronchospasm, Dyspnea, Cough, Urticaria,<br />Rash, Pruritus, Erythema, Flushing, Throat<br />irritation, Paresthesias, Hypoesthesia oral,<br />Dysgeusia, Nausea, Anxiety, Pyrexia,<br />Headache</td></tr><tr><td style="width:172px">Metabolism and Nutrition Disorders</td><td style="width:237px">Hyperkalaemia<br />Hospital acquired hyponatraemia*</td></tr><tr><td style="width:172px">Nervous system disorders</td><td style="width:237px">Acute hyponatraemic encephalopathy*</td></tr><tr><td style="width:172px">General Disorders and Administration Site<br />Conditions</td><td style="width:237px">Infusion Site Reactions manifested by one or<br />more of the following symptoms: Phlebitis,<br />Infusion site inflammation, Infusion site<br />swelling, Infusion site rash, Infusion site<br />pruritus, Infusion site erythema, Infusion site<br />pain, Infusion site burning</td></tr></tbody></table><p>*Hospital acquired hyponatraemia may cause irreversible brain injury and death,<br />due to development of acute hyponatraemic encephalopathy, frequency unknown<br />(see sections 4.2. 4.4, 4.5).<br />The following adverse reactions have been reported spontaneously during the use<br />of other sodium-lactate containing solutions:<br />&bull; Hypersensitivity: Laryngeal oedema (Quincke&#39;s oedema), skin swelling, Nasal<br />congestion, Sneezing<br />&bull; Electrolyte disturbances<br />&bull; Hypervolaemia<br />&bull; Panic Attack<br />&bull; Other infusion site reactions: Infection at the site of injection, Extravasation,<br />Infusion site anesthesia (numbness)<br /><u><strong>Reporting of suspected adverse reactions</strong></u><br />Reporting suspected adverse reactions after authorisation of the medicinal product<br />is important. It allows continued monitoring of the benefit/risk balance of the<br />medicinal product.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>An excessive volume or too high a rate of administration of Compound Sodium<br />Lactate solution may lead to fluid and sodium overload with a risk of oedema<br />(peripheral and/or pulmonary), particularly when renal sodium excretion is<br />impaired. In this case extra renal dialysis may be necessary.<br />Excessive administration of potassium may lead to the development of<br />hyperkalaemia, especially in patients with renal impairment. Symptoms include<br />paresthesia of the extremities, muscle weakness, paralysis, cardiac arrhythmias,<br />heart block, cardiac arrest, and mental confusion.<br />Excessive administration of calcium salts may lead to hypercalcaemia. Symptoms<br />of hypercalcaemia may include anorexia, nausea, vomiting, constipation,<br />abdominal pain, muscle weakness, mental disturbances, polydipsia, polyuria,<br />nephrocalcinosis, renal calculi, and, in severe cases, cardiac arrhythmias and coma.<br />Too rapid intravenous injection of calcium salts may also lead to many of the<br />symptoms of hypercalcaemia as well as to chalky taste, hot flushes, and peripheral<br />vasodilatation. Mild asymptomatic hypercalcaemia will usually resolve on<br />stopping administration of calcium and other contributory drugs such as vitamin D.<br />If hypercalcaemia is severe, urgent treatment (such as loop diuretics,<br />haemodialysis, calcitonin, bisphosphonates, trisodium edetate) is required.<br />Excessive administration of lactate may lead to metabolic alkalosis. Metabolic<br />alkalosis may be accompanied by hypokalaemia, Symptoms may include mood<br />changes, tiredness, shortness of breath, muscle weakness and irregular heartbeat.<br />Muscle hypertonicity, twitching, and tetany may develop especially in<br />hypocalcaemic patients. Treatment of metabolic alkalosis due to bicarbonate<br />overdose consists mainly of appropriate correction of fluid and electrolyte balance.<br />Replacement of calcium, chloride, and potassium may be of particular importance.<br />When overdose is related to medications added to the solution infused, the signs<br />and symptoms of over infusion will be related to the nature of the additive being<br />used. In the event of accidental over infusion, treatment should be discontinued<br />and the patient should be observed for the appropriate signs and symptoms related<br />to the drug administered. The relevant symptomatic and supportive measures<br />should be provided as necessary</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group (ATC code): B05BB01 &ldquo;Electrolytes&rdquo;<br />Compound Sodium Lactate solution is an isotonic solution of electrolytes. The<br />constituents of Compound Sodium Lactate Solution and their concentrations are<br />designed to match those of plasma.<br />The pharmacological properties of the Compound Sodium Lactate solution are<br />those of its components (sodium, potassium, calcium, chloride and lactate). The<br />main effect of Compound Sodium Lactate Solution is the expansion of the<br />extracellular compartment including both the interstitial fluid and the intravascular<br />fluid.<br />The lactate is metabolised into bicarbonate, mainly in the liver, and produces an<br />alkalinising effect on the plasma<br />In healthy volunteers receiving Compound Sodium Lactate Solution, central<br />venous pressure changes were associated with a secretion of atrial natriuretic<br />peptide<br />In healthy volunteers, Compound Sodium Lactate Solution decreased serum<br />osmolality, increased blood pH, and the time until first urination was shorter than<br />that with normal saline.<br />There is no significant change in glucagon, norepinephrine, epinephrine, blood<br />glucose and insulin levels in aortic surgery patients receiving Compound Sodium<br />Lactate Solution.<br />When medication is added to Compound Sodium Lactate Solution, the overall<br />pharmacodynamics of the solution will depend on the nature of the drug used.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The pharmacokinetic properties of the Compound Sodium Lactate solution are<br />those of the ions its composition includes (sodium, potassium, calcium and<br />chloride).<br />Infusion of Compound Sodium Lactate Solution in normal hemodynamically stable<br />adults does not increase circulating lactate concentrations.<br />The pharmacokinetics of D-lactate and L-lactate are similar. The lactate in<br />Compound Sodium Lactate solution is metabolized by both oxidation and<br />gluconeogenesis, predominantly in the liver, and bicarbonate is generated by both<br />processes over 1-2 h.<br />When medication is added to Compound Sodium Lactate Solution, the overall<br />pharmacokinetics of the solution will depend on the nature of the drug used.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical safety data of Compound Sodium Lactate Solution in animals are not<br />relevant since its constituents are physiological components in animal and human<br />plasma.<br />Toxic effects are not to be expected under the condition of clinical application.<br />The safety of potential additives should be considered separately</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Water for Injections</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ceftriaxone must not be mixed with calcium-containing solutions including<br />Compound Sodium Lactate solution. See also sections 4.3 and 4.4.<br />As with all parenteral solutions additives may be incompatible. Compatibility of<br />the additives with the Compound Sodium Lactate solution and Viaflo container<br />must be assessed before addition. After addition of the additive, incompatibility<br />may become visible by a possible colour change and/or the appearance of<br />precipitates, insoluble complexes or crystals.<br />The Instructions for Use of the medication to be added and other relevant literature<br />must be consulted.<br />Before adding a substance or medication, verify that it is soluble and/or stable in<br />water and that the pH range of Compound Sodium Lactate solution is appropriate<br />(pH 5.0 to 7.0).<br />When making additions to Compound Sodium Lacate solution, aseptic technique<br />must be used. Mix the solution thoroughly when additives have been introduced.<br />Do not store solutions containing additives.<br />As a guidance the following medications are incompatible with the Compound<br />Sodium Lactate solution (non-exhaustive listing):<br />Medications incompatible with Compound Sodium Lactate Solution<br />Aminocaproic acid<br />Amphotericin B<br />Metaraminol tartrate<br />Cefamandole<br />Ceftriaxone<br />Cortisone acetate<br />Diethylstilbestrol<br />Etamivan<br />Ethyl alcohol<br />Phosphate and carbonate solutions<br />Oxytetracycline<br />Thiopental sodium<br />Versenate disodium<br />Medications with partial incompatibility with Compound Sodium Lactate Solution:<br />Tetracycline stable for 12 hours<br />Ampicillin sodium<br />concentration of 2%-3% stable for 4 hours<br />concentration &gt;3% must be given within 1 hour<br />Minocycline stable for 12 hours</p><p>Doxycycline stable for 6 hours<br />Additives known or determined to be incompatible should not be used.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                48 months for plastic bottle.
24 months for NPVC bag.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C<br />No special precautions for storage.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The product is a clear, colorless solution in over wrapped Non-PVC Bag with two<br />SFC ports and Polyethylene plastic bottle.<br />The solutions are supplied in 250ml, 500 ml and 1000 ml</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>After opening the container, the contents should be used immediately and should<br />not be stored for a subsequent infusion.<br />Discard after single use.<br />Discard any unused portion.<br />Do not reconnect partially used bags.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Pharmaceutical Solutions Industry Ltd.
Industrial Estate, Phase-2,
Road No. 208, Str. - 203
P O Box 17476
Jeddah 21484
Western Province
Saudi Arabia
Phone: +966-12-6361383
FAX: +966-12-6379460
Website: http://www.psiltd.com
8. Marketing authorization number(s)
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                April 2019
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>